Regulation of heme oxygenase-1 by biliverdin reductase
胆绿素还原酶对血红素加氧酶-1 的调节
基本信息
- 批准号:6892123
- 负责人:
- 金额:$ 22.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-07-15 至 2007-04-30
- 项目状态:已结题
- 来源:
- 关键词:biological signal transductioncell lineenzyme activityenzyme induction /repressionenzyme inhibitorsgel mobility shift assaygene expressionheme oxygenaseimmunoprecipitationisozymeslaboratory rabbitnorthern blottingsnuclear runoff assayoxidative stressphosphorylationpolymerase chain reactionprotein kinase Cprotein signal sequenceserine threonine protein kinasesite directed mutagenesistranscription factorwestern blottings
项目摘要
DESCRIPTION (provided by applicant): Heme oxygenase (HO) activity is vital to a host of biological functions including cellular defense mechanisms, neuronal activity, vascular tone and male reproduction. The enzyme system oxidatively cleaves the heme molecule to biliverdin and carbon monoxide, a signal molecule. Biliverdin is reduced to bilirubin, an antioxidant, by biliverdin reductase (BVR). We have identified 3 HO isozymes: HO-1 (HSP-32), HO-2 and HO-3. HO-1 is exquisitely sensitive to environmental agents that cause oxidative stress and activate MAP kinase signal transduction pathways (e.g. 02 free radicals) as well as carcinogenesis and viral infections (e.g. Herpes, HIV). HO-2 and HO-3 are constitutively expressed. We have previously shown that HO-1 levels rapidly increase in response to oxidative stress both at the transcript and protein levels. The levels, however, rapidly decline with removal of the stimulus. Recently we identified HO-1 as a phosphoprotein. This type of protein modification can be of significance to protein stability and activity. Also, we discovered BVR to be a serine/threonine kinase and an activator of protein kinase C (PKC). PKC is upstream of the MAP kinase signaling pathway. On the other hand, we found that heme degradation product, biliverdin, is an in vivo inhibitor of HO activity and, a most effective inhibitor of PKC. Collectively, these findings lead us to hypothesize that a mechanism for the regulation of HO-1 expression by environmental oxidative stress involves both the kinase and the reductase activities of BVR: As a kinase, it activates the PKC/MAP kinase signaling pathway; and, as a reductase, it circumvents inhibition of the signaling pathway by biliverdin. We further hypothesize that phosphorylation is required for HO-1 activity and/or stability; hence, control of biliverdin production. These hypotheses will be tested by: 1) investigating the significance of HO-1 phosphorylation to its activity; and, examining whether rapid turnover of the induced HO-1 reflects a difference in its phosphorylation state under normal and induced conditions; 2) determining whether HO-1 is a phosphorylation substrate for BVR and/or PKC; 3) analyzing the regulatory role of BVR on induction of HO-1 gene expression through activation of the MAP kinase pathway; and; 4) assessing the effect of biliverdin on MAP kinase pathway activation. H202 will be utilized as the generator of 02 radicals. COS cells transfected with adenoviral vectors of effectors or their mutated counterparts will be used as the experimental model.
描述(由申请人提供):血红素加氧酶(HO)活性对于许多生物功能至关重要,包括细胞防御机制、神经元活动、血管张力和男性生殖。酶系统将血红素分子氧化裂解为胆绿素和一氧化碳(一种信号分子)。胆绿素被胆绿素还原酶 (BVR) 还原为胆红素(一种抗氧化剂)。我们已经鉴定出 3 种 HO 同工酶:HO-1 (HSP-32)、HO-2 和 HO-3。 HO-1 对引起氧化应激并激活 MAP 激酶信号转导途径(例如 02 自由基)以及致癌和病毒感染(例如疱疹、HIV)的环境因素极其敏感。 HO-2和HO-3是组成型表达的。我们之前已经表明,HO-1 水平在转录物和蛋白质水平上响应氧化应激而迅速增加。然而,随着刺激措施的取消,该水平迅速下降。最近我们鉴定出 HO-1 是一种磷蛋白。这种类型的蛋白质修饰对于蛋白质的稳定性和活性具有重要意义。此外,我们还发现 BVR 是一种丝氨酸/苏氨酸激酶和蛋白激酶 C (PKC) 的激活剂。 PKC 是 MAP 激酶信号通路的上游。另一方面,我们发现血红素降解产物胆绿素是 H2O2 活性的体内抑制剂,也是 PKC 最有效的抑制剂。总的来说,这些发现使我们推测环境氧化应激调节 HO-1 表达的机制涉及 BVR 的激酶和还原酶活性: 作为激酶,它激活 PKC/MAP 激酶信号通路;而且,作为一种还原酶,它可以绕过胆绿素对信号通路的抑制。我们进一步假设 HO-1 活性和/或稳定性需要磷酸化;因此,控制胆绿素的产生。这些假设将通过以下方式进行检验:1)研究HO-1磷酸化对其活性的重要性;并检查诱导的 HO-1 的快速周转是否反映了正常和诱导条件下其磷酸化状态的差异; 2)确定HO-1是否是BVR和/或PKC的磷酸化底物; 3)分析BVR通过激活MAP激酶途径诱导HO-1基因表达的调节作用;和; 4)评估胆绿素对MAP激酶途径激活的影响。 H 2 O 2 将用作O 2 自由基的产生剂。转染效应子腺病毒载体或其突变对应物的 COS 细胞将用作实验模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mahin D. Maines其他文献
Mahin D. Maines的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mahin D. Maines', 18)}}的其他基金
Regulation of heme oxygenase-1 by biliverdin reductase
胆绿素还原酶对血红素加氧酶-1 的调节
- 批准号:
7847968 - 财政年份:2009
- 资助金额:
$ 22.44万 - 项目类别:
Regulation of heme oxygenase-1 by biliverdin reductase
胆绿素还原酶对血红素加氧酶-1 的调节
- 批准号:
7061316 - 财政年份:2003
- 资助金额:
$ 22.44万 - 项目类别:
Regulation of heme oxygenase-1 by biliverdin reductase
胆绿素还原酶对血红素加氧酶-1 的调节
- 批准号:
6597192 - 财政年份:2003
- 资助金额:
$ 22.44万 - 项目类别:
Regulation of heme oxygenase-1 by biliverdin reductase
胆绿素还原酶对血红素加氧酶-1 的调节
- 批准号:
7650440 - 财政年份:2003
- 资助金额:
$ 22.44万 - 项目类别:
Regulation of heme oxygenase-1 by biliverdin reductase
胆绿素还原酶对血红素加氧酶 1 的调节
- 批准号:
7826827 - 财政年份:2003
- 资助金额:
$ 22.44万 - 项目类别:
Regulation of heme oxygenase-1 by biliverdin reductase
胆绿素还原酶对血红素加氧酶-1 的调节
- 批准号:
7496125 - 财政年份:2003
- 资助金额:
$ 22.44万 - 项目类别:
Regulation of heme oxygenase-1 by biliverdin reductase
胆绿素还原酶对血红素加氧酶-1 的调节
- 批准号:
6777639 - 财政年份:2003
- 资助金额:
$ 22.44万 - 项目类别:
Regulation of heme oxygenase-1 by biliverdin reductase
胆绿素还原酶对血红素加氧酶-1 的调节
- 批准号:
7319814 - 财政年份:2003
- 资助金额:
$ 22.44万 - 项目类别:
Regulation of heme oxygenase-1 by biliverdin reductase
胆绿素还原酶对血红素加氧酶 1 的调节
- 批准号:
8106400 - 财政年份:2003
- 资助金额:
$ 22.44万 - 项目类别:
Heme Oxygenase-Regulation, Function&Clinical Application
血红素加氧酶调节、功能
- 批准号:
6556791 - 财政年份:2003
- 资助金额:
$ 22.44万 - 项目类别:
相似国自然基金
马口鱼精原干细胞系基因编辑与借腹怀胎研究
- 批准号:32373130
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
系统性红斑狼疮粒-单核-树突细胞系中PLSCR1介导的I型干扰素诱导表达特征及调控机制研究
- 批准号:82300805
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
食蟹猴原始内胚层干细胞系的建立、谱系发生机制及谱系示踪
- 批准号:32270862
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
库蠓细胞系的建立及其在蠓传病毒研究中的应用
- 批准号:32260896
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
干扰BMP信号通路逆转EGFR突变型肺腺癌继发耐药细胞系干性提高EGFR TKIs和放疗敏感性的研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Identifying and targeting collateral lethal vulnerabilities in cancers
识别并针对癌症的附带致命弱点
- 批准号:
10563469 - 财政年份:2023
- 资助金额:
$ 22.44万 - 项目类别:
Cellular and Metabolic Dysfunction in Sepsis-Induced Immune Paralysis
脓毒症引起的免疫麻痹中的细胞和代谢功能障碍
- 批准号:
10724018 - 财政年份:2023
- 资助金额:
$ 22.44万 - 项目类别:
A cell model of YARS2-associated childhood-onset mitochondrial disease
YARS2 相关的儿童期发病线粒体疾病的细胞模型
- 批准号:
10575369 - 财政年份:2023
- 资助金额:
$ 22.44万 - 项目类别:
A Generalizable Photo-Crosslinking Strategy to Identify Tyrosine Phosphatase Substrates
识别酪氨酸磷酸酶底物的通用光交联策略
- 批准号:
10612641 - 财政年份:2023
- 资助金额:
$ 22.44万 - 项目类别:
GPR39 as a Therapeutic Target in Aging-Related Vascular Cognitive Impairment and Dementia
GPR39 作为衰老相关血管认知障碍和痴呆的治疗靶点
- 批准号:
10734713 - 财政年份:2023
- 资助金额:
$ 22.44万 - 项目类别: